Your search returned 3 results. Subscribe to this search

Not what you expected? Check for suggestions
|
1. Favorable outcomes and reduced toxicity with a novel vinblastine-based non-high dose methotrexate (HDMTX) regimen (modified MCP-842) in pediatric anaplastic large cell lymphoma (ALCL): experience from India

by Vijayasekharan K | Prasad M | Pradhan ND | Phillip D | Gujral S | Shet T | Sridhar E | Kembhavi S | Shah S | Banavali SD | Narula G [Corresponding Author].

In Leukemia & Lymphoma
Material type: article Article; Format: print Publisher: 2020Availability: Items available for loan: Tata Memorial Hospital (1).

2. PO-207 Upfront Addition of Sorafenib and Cladribine Based Chemotherapy in FMS-Like-Tyrosine Kinase-3 Internal Tandem Duplication (FLT3-ITD) Mutated Pediatric-Acute Myeloid Leukemia (AML): A Single Centre Experience.

by Pradhan ND | Vijayasekharan K | Tandon S | Sankaran H | Prasad M | Narula G | Patkar N | Tembhare P | Subrahmanian PG | Banavali S.

In Pediatric Blood & Cancer
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

3. Treatment of Langerhans Cell Histiocytosis with a Modified Risk-Adapted Protocol- Experience from a Tertiary Cancer Institute in India.

by Narula G [Corresponding Author] | Pradhan ND | Arora B | Banavali SD.

In Pediatric Blood & Cancer
Material type: serial Continuing resource; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

Powered by Koha